Interleukin-10 (IL-10) ameliorates corneal disease in a mouse model of recurrent herpetic keratitis

被引:28
|
作者
Keadle, TL
Stuart, PM
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Microbiol & Mol Pathogenesis, St Louis, MO 63110 USA
关键词
interleukin-10 (IL-10); herpetic stromal keratitis; Delayed Type Hypersensitivity (DTH);
D O I
10.1016/j.micpath.2004.09.003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Interleukin 10 (IL-10), a moderator of Delayed Type Hypersensitivity (DTH) responses, has been demonstrated to be present late in acute HSV corneal infection and may help limit blinding inflammatory lesions there. In contrast, IL-10 is present early in the development of recurrent herpetic stromal keratitis (HSK) lesions in mice. To determine the role of IL-10 and DTH responses in recurrent HSK, we examined DTH responses and disease parameters in latently infected IL-10 knock out (KO) mice, and latently infected normal mice that were untreated cr received anti-IL-10 antibodies or recombinant IL-10 following ultraviolet-B stimulated ocular HSV recurrence. Low DTH responses were associated with less severe corneal disease while high DTH responses were associated with greater corneal disease. In IL-10 KO mice, and in normal mice given anti-IL-10 antibodies, corneal opacification was increased and DTH responses were significantly prolonged. Normal mice receiving rIL-10 by ocular and intra-peritoneal routes had less severe corneal lesions. Our results indicate that IL-10 and DTH responses play an important role in the pathogenesis of recurrent HSK in mice. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:13 / 21
页数:9
相关论文
共 50 条
  • [1] Interleukin-10 (IL-10) genotypes in inflammatory bowel disease
    Tagore, A
    Gonsalkorale, WM
    Pravica, V
    Hajeer, AH
    McMahon, R
    Whorwell, PJ
    Sinnott, PJ
    Hutchinson, IV
    TISSUE ANTIGENS, 1999, 54 (04): : 386 - 390
  • [2] Interleukin-10 (IL-10) augments allograft arterial disease - Paradoxical effects of IL-10 in vivo
    Furukawa, Y
    Becker, G
    Stinn, JL
    Shimizu, K
    Libby, P
    Mitchell, RN
    AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (06): : 1929 - 1939
  • [3] INTERLEUKIN-10 (IL-10) IN HUMAN-MILK
    GAROFALO, R
    CHHEDA, S
    RASSIN, DK
    MEI, F
    PALKOWETZ, KH
    GOLDMAN, AS
    FASEB JOURNAL, 1995, 9 (03): : A287 - A287
  • [4] INTERLEUKIN-10 (IL-10) IN HUMAN-MILK
    GAROFALO, R
    CHHEDA, S
    MEI, F
    PALKOWETZ, KH
    RUDLOFF, HE
    SCHMALSTIEG, FC
    GOLDMAN, AS
    PEDIATRIC RESEARCH, 1994, 35 (04) : A11 - A11
  • [5] INVOLVEMENT OF INTERLEUKIN-10 (IL-10) IN INFLAMMATORY BOWEL-DISEASE (IBD)
    KOPPEN, T
    NIELSEN, OH
    ERIKSEN, J
    KIRMAN, I
    GASTROENTEROLOGY, 1995, 108 (04) : A851 - A851
  • [6] Polymorphism in the interleukin-10 (IL-10) gene in patients with inflammatory bowel disease
    Aithal, PG
    Grove, J
    Daly, AK
    Han, S
    Welfare, M
    Jones, DEJ
    Day, CP
    Hudson, M
    GUT, 1998, 42 : A46 - A46
  • [7] Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy
    Murray, HW
    Lu, CM
    Mauze, S
    Freeman, S
    Moreira, AL
    Kaplan, G
    Coffman, RL
    INFECTION AND IMMUNITY, 2002, 70 (11) : 6284 - 6293
  • [8] AN INTERLEUKIN-10 (IL-10) INHIBITORY FACTOR (IL-10IF) FROM PLATELETS
    LASLEY, MV
    LU, LJ
    FISHER, RH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 170 - 170
  • [9] INHIBITION OF INTERLEUKIN-10 (IL-10) PRODUCTION BY FLUTICASONE (FLU)
    KONZ, KR
    LU, LJ
    FISHER, RH
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1995, 95 (01) : 300 - 300
  • [10] REGULATION OF CLL BY INTERLEUKIN-10 - ROLE OF ANTISENSE IL-10
    FERNANDES, H
    BARCHUK, W
    FERNANDES, G
    RAMACHANDRA, S
    CHOU, CC
    RAVECHE, E
    ONCOLOGY REPORTS, 1995, 2 (06) : 985 - 989